{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T01:01:20Z","timestamp":1768093280637,"version":"3.49.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001511","name":"Auckland Medical Research Foundation","doi-asserted-by":"publisher","award":["1210003"],"award-info":[{"award-number":["1210003"]}],"id":[{"id":"10.13039\/501100001511","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Buchanan Charitable Foundation","award":["13\/692"],"award-info":[{"award-number":["13\/692"]}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["14\/018"],"award-info":[{"award-number":["14\/018"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.ejpb.2014.12.005","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T19:14:52Z","timestamp":1418152492000},"page":"378-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"PB","title":["Sustained intravitreal delivery of connexin43 mimetic peptide by poly(d,l-lactide-co-glycolide) acid micro- and nanoparticles \u2013 Closing the gap in retinal ischaemia"],"prefix":"10.1016","volume":"95","author":[{"given":"Ying-Shan","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin R.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kailun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helen V.","family":"Danesh-Meyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilva D.","family":"Rupenthal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2014.12.005_b0005","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/S0039-6257(03)00008-0","article-title":"Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage","volume":"48","author":"Lipton","year":"2003","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejpb.2014.12.005_b0010","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1442-9071.2009.02108.x","article-title":"Possible neuroprotective effect of brimonidine in a mouse model of ischaemic optic neuropathy","volume":"37","author":"Goldenberg-Cohen","year":"2009","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ejpb.2014.12.005_b0015","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1093\/brain\/awm257","article-title":"Astrocyte-derived CNTF switches mature RGCs to a regenerative state following inflammatory stimulation","volume":"130","author":"M\u00fcller","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.ejpb.2014.12.005_b0020","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.0953-816X.2003.03107.x","article-title":"CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathway","volume":"19","author":"Ji","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.ejpb.2014.12.005_b0025","first-page":"1783","article-title":"Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma","volume":"13","author":"Jiang","year":"2007","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ejpb.2014.12.005_b0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2011.06.023","article-title":"Retinal ganglion cells survival in a glaucoma model by GDNF\/Vit E PLGA microspheres prepared according to a novel microencapsulation procedure","author":"Checa-Casalengua","year":"2011","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejpb.2014.12.005_b0035","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.exer.2009.02.015","article-title":"Effects of different neurotrophic factors on the survival of retinal ganglion cells after a complete intraorbital nerve crush injury: a quantitative in vivo study","volume":"89","author":"Parrilla-Reverter","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejpb.2014.12.005_b0040","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1097\/BRS.0b013e3181831f7e","article-title":"Neuroprotective effects of caspase-3 inhibition on functional recovery and tissue sparing after acute spinal cord injury","volume":"33","author":"Citron","year":"2008","journal-title":"Spine"},{"key":"10.1016\/j.ejpb.2014.12.005_b0045","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/brain\/awr338","article-title":"Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia","volume":"135","author":"Danesh-Meyer","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.ejpb.2014.12.005_b0050","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1167\/iovs.09-4847","article-title":"Immunolocalization of gap junction protein connexin43 (GJA1) in the human retina and optic nerve","volume":"51","author":"Kerr","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2014.12.005_b0055","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.expneurol.2011.12.027","article-title":"High pressure-induced retinal ischaemia reperfusion causes upregulation of gap junction protein connexin43 prior to retinal ganglion cell loss","volume":"234","author":"Kerr","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejpb.2014.12.005_b0060","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1167\/iovs.10-6318","article-title":"Response of retinal connexin43 to optic nerve injury","volume":"52","author":"Chew","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2014.12.005_b0065","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1523\/JNEUROSCI.18-07-02520.1998","article-title":"Astrocytic gap junctions remain open during ischemic conditions","volume":"18","author":"Cotrina","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejpb.2014.12.005_b0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1089\/ars.2008.2130","article-title":"Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration","volume":"11","author":"Orellana","year":"2009","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ejpb.2014.12.005_b0075","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.neuropharm.2013.04.050","article-title":"Peptides and peptide-derived molecules targeting the intracellular domains of Cx43: gap junctions versus hemichannels","volume":"75","author":"Iyyathurai","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejpb.2014.12.005_b0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.preteyeres.2014.04.002","article-title":"The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies","volume":"42","author":"Herrero-Vanrell","year":"2014","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejpb.2014.12.005_b0085","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/10717544.2011.589088","article-title":"In vitro release characteristics and cellular uptake of poly(d, l-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides","volume":"18","author":"Chen","year":"2011","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejpb.2014.12.005_b0090","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000310240","article-title":"Pressure-induced retinal ischemia in rats: an experimental model for quantitative study","volume":"203","author":"Buchi","year":"1991","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ejpb.2014.12.005_b0095","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/cne.21481","article-title":"Metabolic and functional profiling of the ischemic\/reperfused rat retina","volume":"505","author":"Sun","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.ejpb.2014.12.005_b0100","doi-asserted-by":"crossref","first-page":"799","DOI":"10.3109\/02652040309178090","article-title":"Poly (d,l-lactide-co-glycolide) microspheres for long-term intravitreal delivery of aciclovir: influence of fatty and non-fatty additives","volume":"20","author":"Martinez-Sancho","year":"2003","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejpb.2014.12.005_b0105","first-page":"675","article-title":"Intravitreal Bioerudivel sustained-release triamcinolone microspheres system (RETAAC). Preliminary report of its potential usefulness for the treatment of diabetic macular edema","volume":"81","author":"Cardillo","year":"2006","journal-title":"Arch. Soc. Esp Oftalmol."},{"key":"10.1016\/j.ejpb.2014.12.005_b0110","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2004.11.027","article-title":"PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution","volume":"290","author":"Mainardes","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.12.005_b0115","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ejpb.2008.01.013","article-title":"Dual agents loaded PLGA nanoparticles: systematic study of particle size and drug entrapment efficiency","volume":"69","author":"Song","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2014.12.005_b0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0378-5173(02)00058-3","article-title":"Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study","volume":"238","author":"Vandervoort","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.12.005_b0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijpharm.2004.01.033","article-title":"Factorial design, physicochemical characterisation and activity of ciprofloxacin-PLGA nanoparticles","volume":"275","author":"Dillen","year":"2004","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.12.005_b0130","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2013.01.018","article-title":"Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo","volume":"167","author":"Xu","year":"2013","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejpb.2014.12.005_b0135","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.1523\/JNEUROSCI.22-10-03977.2002","article-title":"TrkB gene transfer protects retinal ganglion cells from axotomy-induced death in vivo","volume":"22","author":"Cheng","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejpb.2014.12.005_b0140","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jconrel.2004.10.015","article-title":"Microencapsulation by solvent extraction\/evaporation: reviewing the state of the art of microsphere preparation process technology","volume":"102","author":"Freitas","year":"2005","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejpb.2014.12.005_b0145","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.ijpharm.2012.07.019","article-title":"Preservation of biological activity of glial cell line-derived neurotrophic factor (GDNF) after microencapsulation and sterilization by gamma irradiation","volume":"436","author":"Checa-Casalengua","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.12.005_b0150","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/02652040400026442","article-title":"Poly(D, L-lactide-co-glycolide) protein-loaded nanoparticles prepared by the double emulsion method\u2014processing and formulation issues for enhanced entrapment efficiency","volume":"22","author":"Bilati","year":"2005","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejpb.2014.12.005_b0155","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/IJG.0b013e3181d787e5","article-title":"Ocular application of nerve growth factor protects degenerating retinal ganglion cells in a rat model of glaucoma","volume":"20","author":"Colafrancesco","year":"2011","journal-title":"J. Glaucoma"},{"key":"10.1016\/j.ejpb.2014.12.005_b0160","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.vetimm.2005.05.004","article-title":"Use of biodegradable PLGA microspheres as a slow release delivery system for the Boophilus microplus synthetic vaccine SBm7462","volume":"107","author":"Sales-Junior","year":"2005","journal-title":"Vet. Immunol. Immunopathol."},{"key":"10.1016\/j.ejpb.2014.12.005_b0165","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0939-6411(00)00125-9","article-title":"Freeze-drying of polycaprolactone and poly (d,l-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs","volume":"50","author":"Saez","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2014.12.005_b0170","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1016\/j.actbio.2012.03.018","article-title":"Development of injectable, resorbable drug-releasing copolymer scaffolds for minimally invasive sustained ophthalmic therapeutics","volume":"8","author":"Fitzpatrick","year":"2012","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2014.12.005_b0175","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0939-6411(98)00011-3","article-title":"Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants","volume":"45","author":"Blanco","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2014.12.005_b0180","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jconrel.2007.08.004","article-title":"On the design of in situ forming biodegradable parenteral depot systems based on insulin loaded dialkylaminoalkyl-amine-poly(vinyl alcohol)-g-poly(lactide-co-glycolide) nanoparticles","volume":"123","author":"Packhaeuser","year":"2007","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.ejpb.2014.12.005_b0185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijpharm.2007.06.011","article-title":"Controlling the in vitro release profiles for a system of haloperidol-loaded PLGA nanoparticles","volume":"346","author":"Budhian","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2014.12.005_b0190","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1167\/iovs.02-0791","article-title":"Subconjunctival nano-and microparticles sustain retinal delivery of budesonide, a corticosteroid capable of inhibiting VEGF expression","volume":"44","author":"Kompella","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2014.12.005_b0195","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/(SICI)1097-4636(1999)48:3<342::AID-JBM20>3.0.CO;2-7","article-title":"Hydrolytic degradation characteristics of aliphatic polyesters derived from lactic and glycolic acids","volume":"48","author":"Li","year":"1999","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ejpb.2014.12.005_b0200","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/jbm.820110507","article-title":"Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA\/PGA copolymer ratios","volume":"11","author":"Miller","year":"1977","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.ejpb.2014.12.005_b0205","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(01)00200-9","article-title":"Biodegradable microspheres for vitreoretinal drug delivery","volume":"52","author":"Herrero-Vanrell","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2014.12.005_b0210","first-page":"175","article-title":"Clearance of sodium fluorescein incorporated into microspheres from the vitreous after intravitreal injection","volume":"22","author":"Khoobehi","year":"1991","journal-title":"Ophthal. Surg."},{"key":"10.1016\/j.ejpb.2014.12.005_b0215","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1002\/jps.23617","article-title":"Cytotoxicity and vitreous stability of chemically modified connexin43 mimetic peptides for the treatment of optic neuropathy","volume":"102","author":"Chen","year":"2013","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2014.12.005_b0220","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1167\/iovs.06-0510","article-title":"Retinal ischemia and reperfusion causes capillary degeneration: similarities to diabetes","volume":"48","author":"Zheng","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2014.12.005_b0225","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1023\/A:1018822002353","article-title":"PH and osmotic pressure inside biodegradable microspheres during erosion1","volume":"16","author":"Brunner","year":"1999","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2014.12.005_b0230","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3109\/02713689508995797","article-title":"Biodegradation and tissue reaction to intravitreous biodegradable poly(d, l-lactic-co-glycolic)acid microspheres","volume":"14","author":"Giordano","year":"1995","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.ejpb.2014.12.005_b0235","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.mcn.2008.06.005","article-title":"Blocking connexin43 expression reduces inflammation and improves functional recovery after spinal cord injury","volume":"39","author":"Cronin","year":"2008","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ejpb.2014.12.005_b0240","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bjps.2004.12.022","article-title":"Limiting burn extension by transient inhibition of connexin43 expression at the site of injury","volume":"58","author":"Coutinho","year":"2005","journal-title":"Br. J. Plast. Surg."},{"key":"10.1016\/j.ejpb.2014.12.005_b0245","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1167\/iovs.11-8711","article-title":"Improved corneal wound healing through modulation of gap junction communication using connexin43-specific antisense oligodeoxynucleotides","volume":"53","author":"Grupcheva","year":"2012","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2014.12.005_b0250","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1021\/mp200140e","article-title":"Ion-activated in situ gelling systems for antisense oligodeoxynucleotide delivery to the ocular surface","volume":"8","author":"Rupenthal","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2014.12.005_b0255","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/j.cub.2003.09.007","article-title":"Targeting connexin43 expression accelerates the rate of wound repair","volume":"13","author":"Qiu","year":"2003","journal-title":"Curr. Biol."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641114003609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641114003609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T08:42:45Z","timestamp":1566117765000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641114003609"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":51,"alternative-id":["S0939641114003609"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2014.12.005","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustained intravitreal delivery of connexin43 mimetic peptide by poly(d,l-lactide-co-glycolide) acid micro- and nanoparticles \u2013 Closing the gap in retinal ischaemia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2014.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}